Top 3 Health Care Stocks That May Implode This Month
As of July 29, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Pro. Here’s the latest list of major overbought players in this sector. Incyte Corp (NASDAQ: INCY ) On July 28, Incyte reported better-than-expected second-quarter earnings results and raised its FY26 sales guidance. “Our second quarter was marked by broad-based sales growth, continued pipeline progress and strategic business development,” said Bill Meury,...
As of July 29, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down.
When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term.
An asset is typically considered overbought when the RSI is above 70, according to Pro.
Here’s the latest list of major overbought players in this sector.
Incyte Corp (NASDAQ: INCY ) On July 28, Incyte reported better-than-expected second-quarter earnings results and raised its FY26 sales guidance. “Our second quarter was marked by broad-based sales growth, continued pipeline progress and strategic business development,” said Bill Meury, Chief Executive Officer, Incyte.
The company’s stock gained around 11% over the past five days and has a 52-week high of $132.60.
RSI Value: 83.8 INCY Price Action: Shares of Incyte rose 9.3% to close at $129.93 on Tuesday.
Edge Stock Ratings: 92.33 Momentum score with Value at 62.31.
Tenet Healthcare Corp (NYSE: THC ) On July 23, Tenet Healthcare reported better-than-expected second-quarter financial results and raised its FY26 guidance. “Strong same-store revenue growth and effective expense management drove our fundamental outperformance in the second quarter of 2026 compared to our original assumptions,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet.
The company’s stock gained around 40% over the past month and has a 52-week high of $262.68.
RSI Value: 84.2 THC Price Action: Shares of Tenet Healthcare gained 7.9% to close at $262.63 on Tuesday.
AtriCure Inc (NASDAQ: ATRC ) On July 23, AtriCure posted better-than-expected quarterly earnings. “Our team delivered healthy growth and a significant step up in profitability in the second quarter,” said Michael Carrel, President and Chief Executive Officer.
The company’s stock gained around 39% over the past month and has a 52-week high of $43.18.
RSI Value: 79.3 ATRC Price Action: Shares of AtriCure gained 6.4% to close at $39.75 on Tuesday.
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and see how they compare.
Photo via Shutterstock